Thus, the activation of c-fos via a HDAC1/2 containing multiprotein BHC complex may provide an alternative pathway for BMI1 to render more malignant phenotype in the myeloid cell clones, especially in the P16 deleted K562 cells or P16 mutant MDS cells. This evidence concerns the gene FOS and myelodysplastic syndrome.